PANITUMUMAB and NAUSEA

Overview

NAUSEA is the #8 most commonly reported adverse reaction for PANITUMUMAB, manufactured by Amgen, Inc. There are 780 FDA adverse event reports linking PANITUMUMAB to NAUSEA. This represents approximately 2.5% of all 31,648 adverse event reports for this drug.

Patients taking PANITUMUMAB who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

NAUSEA is a less commonly reported adverse event for PANITUMUMAB, but still significant enough to appear in the safety profile.

Other Side Effects of PANITUMUMAB

In addition to nausea, the following adverse reactions have been reported for PANITUMUMAB:

• RASH — 1,722 reports
• DIARRHOEA — 1,526 reports
• DERMATITIS ACNEIFORM — 1,005 reports
• DEATH — 908 reports
• NEUTROPENIA — 886 reports
• SKIN TOXICITY — 850 reports
• HYPOMAGNESAEMIA — 793 reports
• DISEASE PROGRESSION — 712 reports
• NEUROPATHY PERIPHERAL — 688 reports
• COLORECTAL CANCER METASTATIC — 625 reports

Other Drugs Associated with NAUSEA

The following drugs have also been linked to nausea in FDA adverse event reports:

Does PANITUMUMAB cause NAUSEA?

NAUSEA has been reported as an adverse event in 780 FDA reports for PANITUMUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is NAUSEA with PANITUMUMAB?

NAUSEA accounts for approximately 2.5% of all adverse event reports for PANITUMUMAB, making it a notable side effect.

What should I do if I experience NAUSEA while taking PANITUMUMAB?

If you experience nausea while taking PANITUMUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages